Dergiler / Gülhane Tıp Dergisi / 2019 / Cilt: 61 - Sayı: 2

Evaluation of the central corneal thickness, retinal thickness and intraocular pressure in patients with euthyroid Hashimoto’s thyroiditis

Sayfa
41–45
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In the present study, however there was a negative correlation between the antiTPO levels and RT.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aims:There are few data concerning the effects of thyroid disorders on intraocular pressure (IOP), central corneal thickness (CCT) and retinal thickness (RT) and to our knowledge no data have been reported in Hashimoto’s thyroiditis (HT).
📊
Temel Bulgular & Veri:Results:We evaluated 80 eyes of 40 patients with euthyroid HT and 96 eyes of 48 controls.
💡
Sonuç & Katkı:In the present study, however there was a negative correlation between the antiTPO levels and RT.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Aims:There are few data concerning the effects of thyroid disorders on intraocular pressure (IOP), central corneal thickness (CCT) and retinal thickness (RT) and to our knowledge no data have been reported in Hashimoto’s thyroiditis (HT). In this study we aimed to evaluate the alterations in IOP, CCT and RT in patients with euthyroid HT. Methods:In this cross-sectional study we examined IOP, CCT and RT in patients with euthyroid HT and age and gender matched controls. Results:We evaluated 80 eyes of 40 patients with euthyroid HT and 96 eyes of 48 controls. Serum sensitive thyroid stimulating hormone (sTSH) (2.10±1.04 vs 1.92±1.23 uIU/ml), free triiodothyronine (fT3) (3.19±0.43 vs 3.14±0.34 pg/ml), and free tetraiodothyronine (fT4) (1.20±0.14 vs 1.18±0.13 ng/dl) levels were similar between the two groups. No statistically significant difference was observed in mean RT (266.93± 26.46 vs 275.35± 38.81 µm), CCT (533.68±29.28 vs 540.06±29.13 µm), or IOP (13.98±2.42 vs 14.32±2.62 mmHg) between HT patients and controls. In the HT group Anti-TPO was negatively correlated with mean RT (r = −0.227, p = 0.033). Conclusions:We have found no differences in CCT, RT and IOP between euthyroid HT patients and controls. In the present study, however there was a negative correlation between the antiTPO levels and RT.

🔖

Bu Makaleye Atıf Yap

SEYREK, F. N. C., BAŞER, H., UĞURLU, N., YÜLEK, F., ERSOY, R., ÇAĞIL, N., ÇAKIR, B. (2019). Evaluation of the central corneal thickness, retinal thickness and intraocular pressure in patients with euthyroid Hashimoto’s thyroiditis. Gülhane Tıp Dergisi, Cilt: 61 - Sayı: 2, 41–45. https://ajindex.com/articles/161845

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. McLeod DS, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine. 2012; 42(2):252- 265
  2. Ceylan I, Yener S, Bayraktar F, Secil M. Roles of ultrasound and power Doppler ultrasound for diagnosis of Hashimoto thyroiditis in anti-thyroid marker-positive euthyroid subjects. Quant Imaging Med Surg. 2014; 4(4):232-238
  3. Bircan HY, Koc B, Akarsu C, et al. Is Hashimoto’s thyroiditis a prognostic factor for thyroid papillary microcarcinoma? Eur Rev Med Pharmacol Sci. 2014; 18 (13):1910-1915
  4. Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014; 13(4-5):391-397
  5. Pedersen OM, Aardal NP, Larssen TB, Varhaug JE, Myking O,Vik-Mo H. The value of ultrasonography in predicting autoimmune thyroid disease. Thyroid. 2000; 10(3):251-259
  6. Yeh HC, Futterweit W, Gilbert P. Micronodulation: ultrasonographic sign of Hashimoto thyroiditis. J Ultrasound Med. 1996; 15(12):813-819
  7. Acar T, Ozbek SS, Erdogan M, Ozgen AG, Demirel SO. US findings in euthyroid patients with positive antithyroid autoantibody tests compared to normal and hypothyroid cases. Diagn Interv Radiol. 2013; 19(4):265-270
  8. Ozturk BT, Kerimoglu H, Dikbas O, Pekel H, Gonen MS. Ocular changes in primary hypothyroidism. BMC Res Note. 2009; 29;2:266
  9. Pinazo-Durán MD, Iborra FJ, Pons S, Sevilla-Romero E, Gallego-Pinazo R, Muñoz A. Postnatal thyroid hormone supplementation rescues developmental abnormalities induced by congenital-neonatal hypothyroidism in the rat retina. Ophthalmic Res. 2005; 37:225-234
  10. Wartofsky L. Diseases of the thyroid. In Fauci SA, Braunwald E (eds) Harrison’s Principles of Internal Medicine, 14th edn. The McGraw Hill Companies, Philadelphia, pp 212-2035. 1998
  11. Centanni M, Cesareo R, Verallo O, et al. Reversible increase of intraocular pressure in subclinical hypothyroid patients. Eur J Endocrinol. 1997;136(6):595-598
  12. Konuk O, Aktas Z, Aksoy S, Onol M, Unal M. Hyperthyroidism and severity of orbital disease do not change the central corneal thickness in Graves’ ophthalmopathy. Eur J Ophthalmol. 2008; 18(1):125-127
  13. Marcocci C, Vitti P, Cetani F, Catalano F, Concetti R, Pinchera A. Thyroid ultrasonography helps to identify patients with diffuse lymphocytic thyroiditis who are prone to develop hypothyroidism. J Clin Endocrinol Metab. 1991; 72(1):209-213
  14. Atmaca M, Kızıldağ E, Candan Z, Özbay MF, Seven İ. Ocular findings in Sheehan’s syndrome. Graefes Arch Clin Exp Ophthalmo. 201